The effects of changing temperature correction factors on measures of acidity calculated from gastric and oesophageal pH recordings

被引:6
作者
Gardner, JD
Young, W
Sloan, S
Robinson, M
Miner, PB
机构
[1] Sci Org Inc, Chatham, NJ 07928 USA
[2] Blossomtech Inc, Apex, NC USA
[3] Janssen Pharmaceut Inc, Titusville, NJ USA
[4] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Fdn Digest Res, Oklahoma City, OK USA
关键词
D O I
10.1111/j.1365-2036.2006.02787.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Recently, Medtronic notified customers that new correction factors should be used for their Slimline and Zinetics24 single-use, internal-standard pH catheters. Aim and Methods We selected 24-h recordings of oesophageal and gastric pH with the Zinetics24 from our archives for five healthy subjects and for five gastro-oesophageal reflux disease subjects who were studied at baseline and again after 8 days of treatment with a proton-pump inhibitor. All pH values obtained with the old correction factors were rescaled using the new correction factors. Values for median pH, integrated acidity and time pH <= 4 were then calculated from pH values with old and new correction factors. Results The new correction factors changed values for median pH, integrated acidity and time pH <= 4. Values for median pH and integrated acidity changed in a predictable, proportionate way, whereas values for time pH <= 4 did not. Conclusions The new correction factors will not change the interpretation of previously published results with median pH or integrated acidity. In contrast, values for time <= 4 cannot be converted in an obvious way with the new correction factors. Instead, the raw pH data will need to be rescaled and values for time pH <= 4 recalculated using the rescaled pH data.
引用
收藏
页码:629 / 638
页数:10
相关论文
共 10 条
[1]   The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis [J].
Gardner, JD ;
Gallo-Torres, H ;
Sloan, S ;
Robinson, M ;
Miner, PB .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (09) :891-905
[2]   Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux disease patients treated with a proton-pump inhibitor [J].
Gardner, JD ;
Sloan, S ;
Robinson, M ;
Miner, PB .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (01) :133-140
[3]   Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastro-oesophageal reflux disease treated with a proton pump inhibitor [J].
Gardner, JD ;
Sloan, S ;
Miner, PB ;
Robinson, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (07) :955-964
[4]   Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease [J].
Gardner, JD ;
Sloan, S ;
Miner, PB ;
Robinson, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (07) :945-953
[5]   Integrated acidity and rabeprazole pharmacology [J].
Gardner, JD ;
Perdomo, C ;
Sloan, S ;
Hahne, WF ;
Barth, JA ;
Rodriguez-Stanley, S ;
Robinson, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (03) :455-464
[6]  
Gardner JD, 2001, AM J GASTROENTEROL, V96, P1363
[7]   Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: A five-way crossover study [J].
Miner, P ;
Katz, PO ;
Chen, YS ;
Sostek, M .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (12) :2616-2620
[8]   Comparison of the Bravo™ wireless and Digitrapper™ catheter-based pH monitoring systems for measuring esophageal acid exposure [J].
Pandolfino, JE ;
Schreiner, MA ;
Lee, TJ ;
Zhang, Q ;
Boniquit, C ;
Kahrilas, PJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (07) :1466-1476
[9]  
*SYN MED AB, 1994, POL FUNCT TEST SOFTW
[10]  
Williams MP, 1998, ALIMENT PHARM THER, V12, P1079